MediaZest – “Project Completion” update, what about some insight on results for a year finished approaching four months ago?
Published 108 days ago
Following the botched Director Dealings RNS of Tuesday, this afternoon AIM-listed Advanced Oncotherapy has ‘fessed up to another foul-up. This time it refers to an RNS released way back on November 7th last year when the company announced that it had issued 266,668 new shares from the exercise of options at 87.5p per share. Except that it hadn’t.
Published 138 days ago
For years Advanced Oncotherapy (AVO) has ramped its shares to get away placing after placing with ramptastic investor presentations. But that was before I started asking all those horrible questions for which there was no answer. and Winnileaks started obtaining toxic leaked emails. Last night the company had a presentation in London. It has another in Zurich this morning. Warning Swiss folk and tax dodgers quotes about the London chinwag include "everyone left unhappy" and from a long term bull "I am just throwing in the towel." The shares have crashed by 23% to 36p bid so far today. The target for me remains 0p. But for those folks going to the Zurich meeting here here are 15 questions Advanced can't or won't answer:
Published 167 days ago
Advanced Oncotherapy (AVO) has finally fessed up to the truth of its bust up with Sinophi and is paying the Chinese $250,000 to settle - even last week house broker Beaufort was, with an Advanced steer, suggesting the Chinese would be paying Oncotherapy several million quid. Lets remind ourselves of a timetable of lies, deception and non disclosure.
Published 176 days ago
This is becoming something of a ritual. Advanced Oncotherapy (AVO) is tardy in releasing very bad news but eventually fesses up. But it misleads investors. Its (now very clearly former) partner Sinophi then, effectively, accuses it of lying. Oh dear, for the second time Sinophi has stated that (almost insolvent) Advanced is telling porkies.
Published 176 days ago
I had a couple of contacts attending Thursday's attempted rampfest by floundering Advanced Oncotherapy (AVO) hosted (for a fee) by the sleazy IR promoters at Proactive Investors. I am grateful to one financial analyst - who is short of the stock - for his notes.
Published 180 days ago
Yesterday I goaded AIM weasels Advanced Oncotherapy (AVO) to come clean on the status of its relationship with Chinese distributor Sinophi, HERE. It seems the world moves quickly because Advanced has today announced that Sinophi has, as of yesterday, "terminated" its orders and at a stroke the order book goes from $150 million to nil. But this smells all wrong and at the same time means that Advanced may well go bust within five weeks. Let me explain.
Published 181 days ago
Advanced Oncotherapy (AVO) said in September that it would secure additional non dilutive funding by the year end. Today it is clarified where it stands but has neglected to point out how perilous its financial position is. Net current assets will be negative within five weeks which begs a real question regarding whether this company is solvent
Published 194 days ago
AIM (very) bad boy Advanced Oncotherapy (AVO) did its best to ramp its shares following the shock loss of its entire order book back in November. Or was it October? Glitzy promo videos and spoofing share purchases by NEDs phased out to have maximum effect on fooling the gullible managed to get the shares back to c90p. But now folks are looking behind the smokescreen of bullshit and the shares are tumbling again, to 73.5p. Since this company has committed securities fraud my target remains 0p. The questions are mounting fast.
Published 219 days ago
As joint house broker to the exponent of Securities fraud that is Advanced Oncotherapy (AVO), Beaufort has to sound bullish and has thus reiterated its speculative buy stance today. But read the note carefully. Beaufort is frit. I have highlighted key phrases that have not appeared before for you. Key phrases which show goalposts being moved and a broker that is sick of being made to look foolish.
Published 224 days ago
Well, well, well. The Cloudtag (#CTAG) saga has not just whipsawed through the wallets of slackjawed investors, it has upturned this weekly feature. A feature, for the first time since the creation of this list, has made it to #4 without being written by Tom Winnifrith. Behold Is CloudTag sitting on a price-sensitive conversion notice? by Cynical Bear.
Published 224 days ago
Time is running out for Advanced Oncotherapy (AVO) as it scrabbles for additional finance but this time it really needs to start telling the truth to potential backers. In fact before I reveal more leaked emails I invite it to correct some previous lies told now.
Published 228 days ago
Yesterday I published extracts from leaked emails that show that Advanced Oncotherapy (AVO ) kept very bad news regarding China contracts from investors as it launched and conducted an open offer. That is monumentally serious. In the US folks would already be doing a perp walk fort that but even our useless regulators will do something here. In normal circumstances the company would issue a response via RNS but here we are a day and a half later and even though the shares slumped yesterday and are sliding again today we hear only a deafening silence.
Published 230 days ago
AIM promote Advanced Oncotherapy (AVO) and Sinophi have already publicly disagreed as to whether the $120 million order by the Chinese has been "terminated" or not and and on when it was "terminated". Advanced announced the bad news on November 24 suggesting no termination, Sinophi used the T word and said it told Advanced in "early November". A source out East has ensured that I have now obtained access to confidential emails from Sinophi to Advanced which show that Advanced was aware of problems far earlier and at a time when it was soliciting funds from investors. It did not tell those investors. Heads must roll.
Published 233 days ago
In the face of relentless pressure from this website, embattled Advanced Oncotherapy (AVO) yesterday put out a statement attempting to draw a line in the sand over its falling out with Sinophi, whom it had claimed was set to buy $120 million of machines from it. It has failed. the statement begs even more questions and the shares remain utterly uninvestable.
Published 236 days ago
Advanced Oncotherapy's (AVO) much ramped JV with China based Sinophi is falling apart in the most embarrassing of ways. Advanced announced its first deal with Sinophi on March 25 2015, a statement made by Sinophi should have the FCA and AIM regulation crawling all over this one.
Published 239 days ago
Yesterday shares in Advanced Oncotherapy (AVO) plunged after it fessed up that a critical deal worth up to $120 million with a Chinese entity had encountered problems. Those who backed a big fundraise just weeks ago are already 26% down. But the incident begs massive questions about the timeline of disclosure and RNS statements that appear to be utterly untrue. I have written to the FCA & AIM Regulation, as this appears to be market abuse, outlining my very specific concerns and demanding an urgent enquiry and, if appropriate, that sanction be taken against those responsible. The letter is below:
Published 240 days ago
How many commercial orders does Advanced Oncotherapy (AVO) have for its Proton beam machines? I put it to you that the answer is zero but that it has always been zero. This company appears to have over-egged the pudding on a serial basis, allowing it to raise vast sums. The FCA should be now launching an urgent investigation into this matter demanding to see original "commercial sales" paperwork in order to see if Advanced has been as transparent as the rules dictate.